Rich Pharmaceuticals, Inc. is pleased to announce the appointment of Professor Richard L. Chang to the Company’s Medical Advisory Board. Chang is the inventor and patent holder for indications presently being developed by Rich Pharmaceuticals. During his distinguished career, he has authored 121 peer-reviewed journal publications and has presented over 150 scientific abstracts across the world in the field of cancer research.
